-
Millionaire Biohacker Gets Outpaced In Anti-Aging Race By Woman Spending Only $108 Monthly: Here's Her Secret To Success
Monday, November 6, 2023 - 9:47pm | 645In a surprising twist, a woman who spends a mere $108 per month on anti-aging remedies has surpassed millionaire biohacker Bryan Johnson in a leaderboard ranking aimed at tracking the effectiveness of anti-aging practices. What Happened: As per a Business Insider report, Julie Gibson Clark, whose...
-
Wedbush: Restorbio's Therapy For Aging-Related Diseases Has Best-In-Class Potential
Tuesday, February 20, 2018 - 3:39pm | 452Clinical stage biopharma company resTORbio, Inc. (NASDAQ: TORC)'s TORC1 inhibition program uses a protein called serine/threonine kinase that aims to regulate aging and aging-related diseases conditions without undesirable side effects. The Analyst Wedbush analyst Robert Driscoll...
-
Alzheimer's Rates Falling, But Pharma's Search For A Cure Yields No Results
Thursday, July 17, 2014 - 11:12am | 691Mixed news came out this week on research into Alzheimer's. New studies suggest the rate of Alzheimer's and other forms of dementia is dropping in the United States and other developed countries. Meanwhile, Big Pharma's years-long battle to find a treatment, if not a cure,...